Alcohol Addiction – Pipeline Review, H2 2020

Global Markets Direct’s, ‘Alcohol Addiction – Pipeline Review, H2 2020’, provides an overview of the Alcohol Addiction pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Alcohol Addiction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Alcohol Addiction and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

– The report provides a snapshot of the global therapeutic landscape of Alcohol Addiction

– The report reviews pipeline therapeutics for Alcohol Addiction by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved Alcohol Addiction therapeutics and enlists all their major and minor projects

– The report assesses Alcohol Addiction therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

– The report summarizes all the dormant and discontinued pipeline projects

– The report reviews latest news related to pipeline therapeutics for Alcohol Addiction

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Alcohol Addiction

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Alcohol Addiction pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

Adial Pharmaceuticals Inc

Amygdala Neurosciences Inc

Aptinyx Inc

Assuage Pharmaceuticals Inc

Astraea Therapeutics LLC

AstraZeneca Plc

Avicanna Inc

BioCorRx Inc

Bioprojet SCR

Chronos Therapeutics Ltd

Colorado Research Partners LLC

Confluence Pharmaceuticals LLC

Corcept Therapeutics Inc

Curemark LLC

Dicerna Pharmaceuticals Inc

Eli Lilly and Co

Kinnov Therapeutics SAS

Kinoxis Therapeutics Pty Ltd

Kyorin Pharmaceutical Co Ltd

Laboratorio Farmaceutico CT Srl

Lohocla Research Corp

Mapreg SAS

Mind Medicine Inc

Montisera Ltd

Naprogenix Inc

Omeros Corp

Opiant Pharmaceuticals Inc

Orphomed Inc

Osmotica Pharmaceutical Corp

Palisades Therapeutics

Pfizer Inc

SK Biopharmaceuticals Co Ltd

Sosei Heptares

South Plains Biotechnology Inc

Syntropharma Ltd

Tonix Pharmaceuticals Holding Corp

VM Discovery Inc

Zynerba Pharmaceuticals Inc

Table of Contents

Table of Contents

Introduction

Alcohol Addiction - Overview

Alcohol Addiction - Therapeutics Development

Alcohol Addiction - Therapeutics Assessment

Alcohol Addiction - Companies Involved in Therapeutics Development

Alcohol Addiction - Drug Profiles

Alcohol Addiction - Dormant Projects

Alcohol Addiction - Discontinued Products

Alcohol Addiction - Product Development Milestones

Appendix

List of Tables

List of Tables

Number of Products under Development for Alcohol Addiction, H2 2020

Number of Products under Development by Companies, H2 2020

Number of Products under Development by Companies, H2 2020 (Contd..1), H2 2020

Number of Products under Development by Universities/Institutes, H2 2020

Products under Development by Companies, H2 2020

Products under Development by Companies, H2 2020 (Contd..1), H2 2020

Products under Development by Companies, H2 2020 (Contd..2), H2 2020

Products under Development by Universities/Institutes, H2 2020

Number of Products by Stage and Target, H2 2020

Number of Products by Stage and Target, H2 2020 (Contd..1), H2 2020

Number of Products by Stage and Mechanism of Action, H2 2020

Number of Products by Stage and Mechanism of Action, H2 2020 (Contd..1), H2 2020

Number of Products by Stage and Route of Administration, H2 2020

Number of Products by Stage and Molecule Type, H2 2020

Alcohol Addiction – Pipeline by Adial Pharmaceuticals Inc, H2 2020

Alcohol Addiction – Pipeline by Amygdala Neurosciences Inc, H2 2020

Alcohol Addiction – Pipeline by Aptinyx Inc, H2 2020

Alcohol Addiction – Pipeline by Assuage Pharmaceuticals Inc, H2 2020

Alcohol Addiction – Pipeline by Astraea Therapeutics LLC, H2 2020

Alcohol Addiction – Pipeline by AstraZeneca Plc, H2 2020

Alcohol Addiction – Pipeline by Avicanna Inc, H2 2020

Alcohol Addiction – Pipeline by BioCorRx Inc, H2 2020

Alcohol Addiction – Pipeline by Bioprojet SCR, H2 2020

Alcohol Addiction – Pipeline by Chronos Therapeutics Ltd, H2 2020

Alcohol Addiction – Pipeline by Colorado Research Partners LLC, H2 2020

Alcohol Addiction – Pipeline by Confluence Pharmaceuticals LLC, H2 2020

Alcohol Addiction – Pipeline by Corcept Therapeutics Inc, H2 2020

Alcohol Addiction – Pipeline by Curemark LLC, H2 2020

Alcohol Addiction – Pipeline by Dicerna Pharmaceuticals Inc, H2 2020

Alcohol Addiction – Pipeline by Eli Lilly and Co, H2 2020

Alcohol Addiction – Pipeline by Kinnov Therapeutics SAS, H2 2020

Alcohol Addiction – Pipeline by Kinoxis Therapeutics Pty Ltd, H2 2020

Alcohol Addiction – Pipeline by Kyorin Pharmaceutical Co Ltd, H2 2020

Alcohol Addiction – Pipeline by Laboratorio Farmaceutico CT Srl, H2 2020

Alcohol Addiction – Pipeline by Lohocla Research Corp, H2 2020

Alcohol Addiction – Pipeline by Mapreg SAS, H2 2020

Alcohol Addiction – Pipeline by Mind Medicine Inc, H2 2020

Alcohol Addiction – Pipeline by Montisera Ltd, H2 2020

Alcohol Addiction – Pipeline by Naprogenix Inc, H2 2020

Alcohol Addiction – Pipeline by Omeros Corp, H2 2020

Alcohol Addiction – Pipeline by Opiant Pharmaceuticals Inc, H2 2020

Alcohol Addiction – Pipeline by Orphomed Inc, H2 2020

Alcohol Addiction – Pipeline by Osmotica Pharmaceutical Corp, H2 2020

Alcohol Addiction – Pipeline by Palisades Therapeutics, H2 2020

Alcohol Addiction – Pipeline by Pfizer Inc, H2 2020

Alcohol Addiction – Pipeline by SK Biopharmaceuticals Co Ltd, H2 2020

Alcohol Addiction – Pipeline by Sosei Heptares, H2 2020

Alcohol Addiction – Pipeline by South Plains Biotechnology Inc, H2 2020

Alcohol Addiction – Pipeline by Syntropharma Ltd, H2 2020

Alcohol Addiction – Pipeline by Tonix Pharmaceuticals Holding Corp, H2 2020

Alcohol Addiction – Pipeline by VM Discovery Inc, H2 2020

Alcohol Addiction – Pipeline by Zynerba Pharmaceuticals Inc, H2 2020

Alcohol Addiction – Dormant Projects, H2 2020

Alcohol Addiction – Dormant Projects, H2 2020 (Contd..1), H2 2020

Alcohol Addiction – Dormant Projects, H2 2020 (Contd..2), H2 2020

Alcohol Addiction – Discontinued Products, H2 2020

List of Figures

List of Figures

Number of Products under Development for Alcohol Addiction, H2 2020

Number of Products under Development by Companies, H2 2020

Number of Products by Top 10 Targets, H2 2020

Number of Products by Stage and Top 10 Targets, H2 2020

Number of Products by Top 10 Mechanism of Actions, H2 2020

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020

Number of Products by Routes of Administration, H2 2020

Number of Products by Stage and Routes of Administration, H2 2020

Number of Products by Molecule Types, H2 2020

Number of Products by Stage and Molecule Types, H2 2020

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports